view counter
view counter

CPMA Reminder Regarding Levamisole

October 30, 2018:

The Canadian Pari-Mutuel Agency (CPMA) is reminding veterinarians and racehorse trainers and owners that Levamisole is a prohibited substance in Canada because it metabolizes into aminorex, a prohibited stimulant. Levamisole should not be administered to a racehorse for any on

Addition To Elimination Guidelines Book

August 1, 2018:

On Wednesday (August 1), the Canadian Pari-Mutuel Agency announced new elimination guidelines to its 2016 Elimination Guidelines Booklet for Cetirizine1, Clodronate2, Dexamethasone, Fluticasone, and Triamcinolone on

Suttie Retiring From The CPMA

June 20, 2018:

The Canadian Pari-Mutuel Agency has announced that its executive director, Steve Suttie, will be retiring at the end of the on

CPMA: How Well Are We Doing?

June 20, 2018:

The Canadian Pari-Mutuel Agency would like feedback in regard to how well it is doing when it comes to deterring the use of prohibited substances in Canadian horse on

Clodronate, Tiludronate Added To Schedule Of Prohibited Drugs

May 31, 2018:

On Thursday (May 31), the Canadian Pari-Mutuel Agency announced that the regulatory amendment to add the drugs clodronate and tiludronate to the Schedule to the Pari-Mutuel Betting Supervision Regulations has been on

CPMA Update On Cobalt

May 10, 2018:

The Canadian Pari-Mutuel Agency (CPMA) would like to provide the Canadian horse racing industry with an update on cobalt testing since it was transferred from the provincial racing commissions in April on

CPMA Memo On Glaucine

July 6, 2017:

On Thursday, July 6, the Canadian Pari-Mutuel Agency issued a memo to the industry stating that although glaucine continues to be classified as prohibited substance under the Pari-Mutuel Betting Supervision Regulations, the CPMA has taken steps to differentiate glaucine abuse from environmental on

Retention-Area Towel Pilot Approved

June 15, 2017:

On Thursday, June 15, the Canadian Pari-Mutuel Agency issued a memo to horsepeople competing on the Woodbine Entertainment Group circuit stating that a proposed pilot project in regard to the stocking of clean towels in the retention areas of Woodbine and Mohawk Racetrack has been on

AGCO Update On Cobalt Testing

April 27, 2017:

On Thursday, April 27, the Alcohol and Gaming Commission of Ontario sent out an informational bulletin in regard to cobalt on

Additional Info On Cobalt Thresholds

April 21, 2017:

Further to the Canadian Pari-Mutuel Agency’s (CPMA) Industry Notice dated April 6, 2017, regarding the implementation of CPMA cobalt testing effective May 1, 2017, the CPMA has received questions about what this means from a practical perspective given that cobalt occurs naturally in the on

Equine Drug Control Presentation Info.

April 18, 2017:

The Canadian Pari-Mutuel Agency (CPMA) in conjunction with Horse Racing Alberta (HRA) will be hosting an information session on the Equine Drug Control on

CPMA Sets New Cobalt Thresholds

April 6, 2017:

A release issued Thursday by The Canadian Pari-Mutuel Agency (CPMA) indicates that the federal agency will be lowering the quantitative threshold for cobalt testing starting May on

Update On Allowed Retention Items

March 28, 2017:

Further to the Notice to Industry dated September 16, 2016, the Canadian Pari-Mutuel Agency (CPMA) has listened to feedback received concerning the number of buckets allowed in with a horse called to test and the prohibition of towels in the retention on

Changes To Urine Collection Containers

March 24, 2017:

Beginning May 1, 2017, the Canadian Pari-Mutuel Agency (CPMA) will be using a new urine collection container for the CPMA equine drug control on

CPMA Exchange Rate Announcement

March 21, 2017:

On Tuesday, March 21, the Canadian Pari-Mutuel Agency announced that, effective Wednesday, March 22, all Canadian racecourse associations will be required to use the Daily Exchange Rate – and not the ‘noon’ or ‘closing’ rate – as reported for the previous day on a particular on

view counter

© 2020 Standardbred Canada. All rights reserved. Use of this site signifies your agreement and compliance with the legal disclaimer and privacy policy.

Firefox 3 Best with IE 7 Built with Drupal